Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelia Papadimitriou

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Free Radical Research|January 6, 2004
Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cellsEfstathia Giannopoulou, Evangelia Papadimitriou
Free Radical Research|August 6, 2004
Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activityChristos Polytarchou, Evangelia Papadimitriou
European Journal of Pharmacology|March 3, 2005
Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activityChristos Polytarchou, Evangelia Papadimitriou
Connective Tissue Research|July 29, 2008
Heparin-binding protein pleiotrophin: an important player in the angiogenic processConstantinos Mikelis, Evangelia Papadimitriou
Recent Patents on Anti-Cancer Drug Discovery|November 21, 2013
Cell surface nucleolin as a target for anti-cancer therapiesMarina Koutsioumpa, Evangelia Papadimitriou
Biochimica Et Biophysica Acta|January 14, 2014
Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migrationEvangelia Pantazaka, Evangelia Papadimitriou
International Journal of Molecular Sciences|May 13, 2023
Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and DiagnosisEvangelia Papadimitriou, Vasiliki K Kanellopoulou
European Journal of Pharmacology|January 22, 2003
Different inhibitors of plasmin differentially affect angiostatin production and angiogenesisMaria Hatziapostolou, Panagiotis Katsoris, Evangelia Papadimitriou
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Pleiotrophin as a possible new target for angiogenesis-related diseases and cancerConstantinos Mikelis, Marina Koutsioumpa, Evangelia Papadimitriou
The Journal of Biological Chemistry|October 4, 2005
Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide geneChristos Polytarchou, Maria Hatziapostolou, Evangelia Papadimitriou
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Free Radical Research|January 6, 2004
Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cellsEfstathia Giannopoulou, Evangelia Papadimitriou
Free Radical Research|August 6, 2004
Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activityChristos Polytarchou, Evangelia Papadimitriou
European Journal of Pharmacology|March 3, 2005
Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activityChristos Polytarchou, Evangelia Papadimitriou
Connective Tissue Research|July 29, 2008
Heparin-binding protein pleiotrophin: an important player in the angiogenic processConstantinos Mikelis, Evangelia Papadimitriou
Recent Patents on Anti-Cancer Drug Discovery|November 21, 2013
Cell surface nucleolin as a target for anti-cancer therapiesMarina Koutsioumpa, Evangelia Papadimitriou
Biochimica Et Biophysica Acta|January 14, 2014
Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migrationEvangelia Pantazaka, Evangelia Papadimitriou
International Journal of Molecular Sciences|May 13, 2023
Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and DiagnosisEvangelia Papadimitriou, Vasiliki K Kanellopoulou
European Journal of Pharmacology|January 22, 2003
Different inhibitors of plasmin differentially affect angiostatin production and angiogenesisMaria Hatziapostolou, Panagiotis Katsoris, Evangelia Papadimitriou
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Pleiotrophin as a possible new target for angiogenesis-related diseases and cancerConstantinos Mikelis, Marina Koutsioumpa, Evangelia Papadimitriou
The Journal of Biological Chemistry|October 4, 2005
Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide geneChristos Polytarchou, Maria Hatziapostolou, Evangelia Papadimitriou
Pageof 9